CORCEPT THERAPEUTICS INC — Director's Dealing 2012

Jun 15, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-06-13

Reporting Person: TURNER JOSEPH L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-13	Stock option (right to buy)	$4.05	A	50000	Acquired	2022-06-13	Common Stock (50000)	Direct

Footnotes

F1: Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 13, 2012, with the final vesting of all remaining shares to occur on or before the date of Corcept's 2013 Annual Meeting.